|
| Status |
Public on Dec 14, 2022 |
| Title |
Plasma_cells_Multiple_Myeloma [T01163] |
| Sample type |
genomic |
| |
|
| Source name |
sorted Plasma cells, from bone marrow of newly diagnosed multiple myeloma patients
|
| Organism |
Homo sapiens |
| Characteristics |
subject id: T01163
diagnosis: multiple myeloma
Sex: female
age: 68
del1p32 status: 0
treatment: VTD
tissue: bone marrow
cell type: sorted plasma cells (CD138+)
|
| Treatment protocol |
sorted plasma cells (CD138+) then frozen (-80°C)
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Nucleospin Tissue Macherey Nagel
|
| Label |
biotin
|
| Label protocol |
Cytoscan Affymetrix Label (DNA labeling reagent)
|
| |
|
| Hybridization protocol |
Cytoscan HD arrays (Affymetrix)
|
| Scan protocol |
Scanner Affymetrix GCS 3000 7G
|
| Data processing |
analysis with the logarithm of ChAS software
|
| |
|
| Submission date |
Oct 26, 2022 |
| Last update date |
Dec 14, 2022 |
| Contact name |
Laura Do Souto Ferreira |
| E-mail(s) |
dosoutoferreira.laura@iuct-oncopole.fr
|
| Organization name |
IUCT
|
| Lab |
Equipe 13 : Hematologie
|
| Street address |
1 Av. Irène Joliot-Curie
|
| City |
Toulouse |
| ZIP/Postal code |
31100 |
| Country |
France |
| |
|
| Platform ID |
GPL16131 |
| Series (1) |
| GSE216574 |
Double-deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor |
|
